The aims of this projects are to assess the feasibility, acceptability, efficacy and cost-effectiveness of annual chlamydia testing among 16–29 year olds in general practice setting and Aboriginal Community Controlled Health Services (ACCHS).
Design & Method
This is a cluster randomised clinical trial of a chlamydia-testing intervention, designed to increase chlamydia testing in general practice and ACCHS. GP clinics and ACCHS have been recruited in 54 postcodes across NSW, VIC, QLD and SA. Men and women aged 16 to 29 years are targeted for chlamydia testing. The intervention is multifaceted and includes incentive payments for GPs and practice nurses/Aboriginal health workers, computer alerts, regular feedback on testing rates and results, and an accredited Chlamydia education and support package). The primary outcome is change in chlamydia prevalence over time. ACCEPt is using Grhanite for data collection to collect clinic consultation data and chlamydia testing and diagnosis data. There are qualitative interviews with clinic staff and patients as well to assess acceptability of the testing intervention.
Due to the large number of sites, progress of recruitment and randomisation is staggered. Recruitment was completed December 2011 and by June 2012 all baseline prevalence surveys will be complete and geographical areas will have been randomised.
This is a world-first study looking at the impact of a chlamydia screening program.
University of Melbourne
La Trobe University
Melbourne Sexual Health Centre
The Royal Women’s Hospital Victoria
Victorian Cytology service
University of Bern
Jane Hocking, Christopher Fairley, Jane Gunn, Basil Donovan, John Kaldor, Nicola Low, Matthew Law, Meredith Temple-Smith, David Regan, David Wilson, John Imrie, Rob Carter, Marian Pitts, Anne Mitchell, Marion Saville, Dorota Gertig, Lena Sanci, Marie Pirotta, Sepehr Tabrizi, Marcus Chen, Margaret Hellard